A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Trial Profile

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Apr 2018

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Breast cancer
  • Focus Pharmacokinetics
  • Sponsors Athenex
  • Most Recent Events

    • 19 Apr 2018 According to Athenex mesia release, compnay has announced initial results of a clinical study in Taiwan in patients with metastatic breast cancer.
    • 22 Jan 2018 Preliminary data presented in an Athenex Media Release.
    • 26 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top